Condition

Pancreatic Cancer, Adult clinical trials and research

• 14Clinical trials
• 10Countries

Newest Pancreatic Cancer, Adult clinical trials

All recruiting trials (14)

• BEFAST: Total Body PET/CT with Ga-68 FAPI for Better Imaging in Cancer

  This study tests whether Ga-68 FAPI-46 Total Body PET/CT can better detect cancer spread and provide fast, clear images for adults with pancreatic or gastroesophageal cancer.

  Recruiting Phase 2 Copenhagen University Hospital, Rigshospitalet · Copenhagen · NCT07629609

• Chronic Stress and Pancreatic Cancer Outcomes in People with Pancreatic Cancer

  This study tests whether ongoing psychological stress affects how pancreatic cancer behaves and responds to treatment in adults.

  Recruiting Shanghai Zhongshan Hospital · Changsha, Hunan and 2 other locations · NCT07529626

• Prehab to get stronger before pancreatic cancer surgery

  This project will test whether adults with pancreatic cancer can follow a combined exercise, nutrition, and symptom-management program during chemotherapy to improve fitness and recovery before surgery.

  Recruiting University of Massachusetts, Worcester · Worester, Massachusetts · NCT07478185

• Surufatinib with Gemcitabine and Nab-paclitaxel as Neoadjuvant Therapy for High-Risk or Borderline Resectable Pancreatic Cancer

  This trial tests whether adding surufatinib to gemcitabine and nab-paclitaxel before surgery helps adults with high-risk resectable or borderline resectable pancreatic cancer.

  Recruiting Phase 3 Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07436741

• Peptamen 1.6 versus Resource HP/HC for nutrition after cephalic pancreaticoduodenectomy

  This tests whether Peptamen 1.6, a hydrolysed whey protein oral supplement, helps malnourished or at-risk adults recover better than a standard high-protein/high-calorie formula after cephalic pancreaticoduodenectomy for pancreatic or periampullary cancer.

  Recruiting Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · Málaga, Málaga · NCT06852014

• Using deep learning and Raman spectroscopy for early cancer diagnosis

  This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.

  Recruiting at 4 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Nanchang, Jiangxi and 3 other locations · NCT06822413

• Monitoring pancreatic health after a new diabetes diagnosis

  We will try a new blood test called Avantect to see if it can detect early pancreatic cancer in people aged 50–84 who were diagnosed with type 2 diabetes within the past six months.

  Recruiting at 22 sites University Hospital Southampton NHS Foundation Trust · Sandbach, Cheshire and 30 other locations · NCT06803771

• Analyzing gut bacteria in pancreatic cancer surgery patients

  This study is trying to see if certain gut bacteria in patients having surgery for pancreatic cancer can help predict complications after the operation.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, BO · NCT06800469

• Using blood markers to predict nerve invasion in pancreatic cancer

  This study is trying to see if certain blood markers can help predict nerve invasion in patients with pancreatic cancer to improve their treatment plans.

  Recruiting University of Las Palmas de Gran Canaria · Las Palmas de Gran Canaria, Las Palmas · NCT06747481

• AI blood test using platelet and immune-cell RNA for early cancer detection and monitoring

  This AI-based blood test profiles platelet and immune-cell RNA to see if it can find common cancers early and track treatment response in adults aged 40 and older.

  Recruiting at 2 sites Dysplasia Diagnostics Limited · Rosario and 3 other locations · NCT06717295

• Adebrelimab and chidamide with gemcitabine plus S-1 for advanced pancreatic cancer

  This study will test whether adding the immunotherapy adebrelimab and the oral drug chidamide to standard chemotherapy (gemcitabine plus S-1) helps people with unresectable locally advanced or metastatic pancreatic cancer respond better or live longer.

  Recruiting Phase 2 Jinling Hospital, China · Nanjing, Jiangsu · NCT06584227

• Early detection of pancreatic cancer using exosome-based biomarkers

  This study is testing a new way to find pancreatic cancer early by looking at tiny particles in the blood that carry specific markers.

  Recruiting at 11 sites City of Hope Medical Center · Phoenix, Arizona and 12 other locations · NCT06388967

• Screening for pancreatic cancer in high-risk individuals

  This study is testing if screening for pancreatic cancer helps high-risk individuals catch the disease early and improve their chances of successful treatment.

  Recruiting Beth Israel Deaconess Medical Center · Boston, Massachusetts · NCT05006131

• Evaluating tumor types in pancreatic cancer patients receiving FOLFIRINOX treatment

  This study is testing how different types of pancreatic cancer respond to the chemotherapy FOLFIRINOX before surgery to see if it helps make the tumors easier to remove.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT03977233

Related topics

Quick answers

How many Pancreatic Cancer, Adult clinical trials are recruiting right now?

14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in China (4 trials), United States (4 trials), United Kingdom (2 trials), Spain (2 trials), Japan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →